Position in OCGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$147,656
+$52,152 QoQ
Shares Held
81,578
+15.3% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Headlands Technologies LLC holds $46,940,061 across 76 Biotechnology names. OCGN ranks #64 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IBRX |
ImmunityBio, Inc.
|
397,170 | $3,046,293 | |
| 2 | NKTR |
Nektar Therapeutics
|
28,244 | $2,032,155 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
|
59,257 | $2,004,664 | |
| 4 | VERA |
Vera Therapeutics, Inc.
|
49,223 | $1,980,241 | |
| 5 | MLTX |
MoonLake Immunotherapeutics
|
97,133 | $1,810,559 | |
| 6 | GPCR |
Structure Therapeutics Inc.
|
37,156 | $1,790,919 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
49,146 | $1,599,210 | |
| 8 | NVAX |
Novavax Inc
|
189,675 | $1,543,954 |
All Filings in OCGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $147,656 | 81,578 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $95,504 | 70,744 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $107,860 | 66,172 | Shares | Sole | 2025-11-12 | |
| 2024-03-31 | $65,924 | 40,198 | Shares | Sole | 2024-05-07 | |
| No filing history on record for this holder in this stock. | ||||||